GSA-MiXeR: A powerful tool to improve our understanding of heritable traits and diseases

FHS
June 4, 2024
7:26 pm

Researchers from the University of Oslo have developed an innovative tool that promises to improve our understanding of heritable human traits and diseases.

Sirolimus by OrphAI Therapeutics for Pulmonary Arterial Hypertension: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 6, 2023

Allen Institute CEO Rui Costa on mapping the brain and paying early-career scientists decent salaries

Mapping the billions of cells that make up the brain is a task mammoth enough to keep hundreds of researchers across continents busy for years.

January 3, 2024

California health workers may face rude awakening with $25 minimum wage law

Nearly a half-million health workers who stand to benefit from California’s nation-leading $25 minimum wage law could be in for a rude awakening if hospitals

April 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.